Key facts
- This page summarizes Jeffrey A. Bluestone's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 May 2025, 20:16.
Jeffrey A. Bluestone - 07 May 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- Director
- Issuer ticker
- GILD
- Reported as of
- 07 May 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 May 2025, 20:16:09 UTC
- Prior SEC filing
- 27 Nov 2024
- Next SEC filing
- 15 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey A. Bluestone filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 08 May 2025.
Change
- Previous filing in this sequence was filed on 27 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001771814
Primary reporting owner
Bluestone Jeffrey
- Relationship
- Director
- Address
- 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone
- Signature date
- 08 May 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +1,516
- Change %
- +36%
- Price
- $0.000000
- Shares after
- 5,713
- Date
- 07 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,516
- Exercise price
- Footnotes
- F1, F2
GILD
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +6,809
- Change %
- Price
- $0.000000
- Shares after
- 6,809
- Date
- 07 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,809
- Exercise price
- $98.90
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
100% of the restricted stock units vested immediately upon the grant date of May 7, 2025.
Footnote F3
100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025.